Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T02598
(Former ID: TTDI01310)
|
|||||
Target Name |
Leukocyte (WBC)
|
|||||
Synonyms |
Human leukocyte
Click to Show/Hide
|
|||||
Gene Name |
NO-GeName
|
|||||
Target Type |
Clinical trial target
|
[1] | ||||
Disease | [+] 1 Target-related Diseases | + | ||||
1 | Postoperative inflammation [ICD-11: 1A00-CA43] | |||||
UniProt ID |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Clinical Trial Drug(s) | [+] 1 Clinical Trial Drugs | + | ||||
1 | IPL 550,260 | Drug Info | Phase 1 | Inflammation | [2] | |
Mode of Action | [+] 1 Modes of Action | + | ||||
Modulator | [+] 1 Modulator drugs | + | ||||
1 | IPL 550,260 | Drug Info | [1] |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | WO patent application no. 2005,0792,17, Oligonucleotide decoys and methods of use. | |||||
REF 2 | Marine natural products and related compounds in clinical and advanced preclinical trials. J Nat Prod. 2004 Aug;67(8):1216-38. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.